Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,114
Total Claims
$991K
Drug Cost
476
Beneficiaries
$2,081
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-31%
Opioid rate vs peers
1.8% vs 2.6% avg
+95%
Cost per patient vs peers
$2,081 vs $1,068 avg
+46%
Brand preference vs peers
13.1% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.8%
Opioid Rate
163
Opioid Claims
$1,995
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,188 claims · $751K
Generic: 7,869 claims · $237K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 113 | $123K |
| Dulaglutide | 79 | $104K |
| Dapagliflozin Propanediol | 85 | $67K |
| Apixaban | 64 | $50K |
| Insulin Glargine,hum.Rec.Anlog | 46 | $35K |
| Empagliflozin | 30 | $33K |
| Liraglutide | 15 | $30K |
| Tirzepatide | 27 | $30K |
| Cariprazine Hcl | 15 | $25K |
| Rivaroxaban | 31 | $22K |
| Rosuvastatin Calcium | 378 | $20K |
| Insulin Glargine,hum.Rec.Anlog | 11 | $19K |
| Sitagliptin Phosphate | 14 | $15K |
| Semaglutide | 14 | $14K |
| Dapaglifloz Propaned/Metformin | 12 | $13K |
Prescribing Profile
Patient Profile
73
Avg Age
44%
Female
1.10
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About